A similar unfavorable prognostic effect was detected in grade-III gliomas (P < 0.05) while no correlation was observed between C1qA, C1qB, and C1qC mRNA expression and the survival probability in gliomas grade-II (Figure 3). The gene discussed is C1QB; the disease is central nervous system cancer.